
Tumor-Killing ‘Cornell Dots’ Enter Their First Therapeutic Trial
Silica-encased fluorescent nanoparticles, otherwise known as “Cornell Dots”, have just entered their first therapeutic trial, following three successful diagnostic human clinical trials during which they






